In a real-world analysis of patients with advanced RCC, the combination of first-line Bavencio and Inlyta was effective and ...

What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do ...

Patients with advanced urothelial carcinoma had prolonged survival with Bavencio and BSC treatment, regardless of diabetes ...

Klug, M.B.A., Appointed Chief Financial Officer and Chief Business Officer; Sophie Jeannin, M.D., Appointed Chief Medical ...

On January 6, 2025, the US Food and Drug Administration (FDA) published final guidance titled “Communications From Firms to Health Care ...

Nemluvio has received approval from the European Commission to treat moderate to severe atopic dermatitis and prurigo ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...

Today, my patients with cystic fibrosis live a near-normal life, but other diseases beg for NIH support. Don't halt NIH ...

Sweden: A recent study published in the Journal of Internal Medicine has highlighted an elevated risk of bleeding in patients ...

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...

III by Panduka Karunanayake Professor in the Department of Clinical Medicineand former Director, Staff Development Centre, University of Colombo The 34th J.E. Jayasuriya Memorial Lecture 14 February ...